|
- IRMS - Nicolae Testemitanu SUMPh
- 1. COLECȚIA INSTITUȚIONALĂ
- MedEspera: International Medical Congress for Students and Young Doctors
- MedEspera 2024
Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12710/28733
Title: | Drugs of choice in hypertensive emergency associated with acute aortic dissection |
Authors: | Prijilevschi, Cristina |
Issue Date: | 2024 |
Publisher: | Instituţia Publică Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” din Republica Moldova |
Citation: | PRIJILEVSCHI, Cristina. Drugs of choice in hypertensive emergency associated with acute aortic dissection. In: MedEspera: the 10th Intern. Medical Congress for Stud. and Young Doctors, 24-27 April 2024: abstract book. Chișinău, 2024, p. 325. ISBN 978-9975-3544-2-4. |
Abstract: | Introduction. Acute aortic dissection is a hypertensive emergency that requires an immediate
reduction of blood pressure (BP) by administering intravenous drug therapy. Diligent control of
BP is the most crucial in order to stop the progression of dissection and prevent target organ
damage.
Aim of study. Aim of study was to select the antihypertensive drugs recommended by
international guidelines for the management of this major emergency.
Methods and materials. The scientific papers in the PubMed database from the last 5 years with
reference to the management of hypertensive emergencies, including acute aortic dissections, were
selected and analyzed.
Results. Studies have shown that for the management of acute aortic dissection, it is recommended
to use adequate analgesia, which includes morphine as it decreases sympathetic output as well. In
the absence of aortic regurgitation, the most favored agent is a beta-blocker, such as esmolol,
labetalol or metoprolol, targeting a heart rate of 60-80 beats/ min and a systolic blood pressure of
100-120 mm/Hg, because the effect of beta-blockers in lowering the heart rate and blood pressure,
helps to reduce the aortic wall tension and limit the extent of dissection. In patients with
contraindications to beta-blockers, diltiazem and verapamil- non dihydropyridine calcium channel
blockers, angiotensin-converting enzyme inhibitor (ACEI) or an angiotensin receptor blocker
(ARB), should be considered. If the systolic blood pressure remains elevated, a combination of a
vasodilator such as nitroprusside or nitroglycerine and β-blocker is preferred.
Conclusion. The drug of first choice has to be a short-acting i/v beta-blocker agent, (esmolol,
labetalol, metoprolol) as it is able to reduce the force of left ventricular ejection, or combined with
a vasodilator in severe hypertension. The use of β-blockers, ACEIs, or ARBs was associated with
benefits in the long- term treatment of aortic dissection. |
metadata.dc.relation.ispartof: | MedEspera: The 10th International Medical Congress for Students and Young Doctors, 24-27 April 2024, Chișinău, Republic of Moldova |
URI: | https://medespera.md/en/books?page=10 http://repository.usmf.md/handle/20.500.12710/28733 |
ISBN: | 978-9975-3544-2-4 |
Appears in Collections: | MedEspera 2024
|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
|